Published on 5 Nov 2022 on Simply Wall St. via Yahoo Finance

Core Laboratories' (NYSE:CLB) earnings have declined over five years, contributing to shareholders...

While it may not be enough for some shareholders, we think it is good to see the Core Laboratories N.V. (NYSE:CLB) share price up 27% in a single quarter. But spare a thought for the long term holders, who have held the stock as it bled value over the last five years. Indeed, the share price is down a whopping 80% in that time. The recent bounce might mean the long decline is over, but we are not confident. The real question is whether the business can leave its past behind and improve itself over the years ahead. While a drop like that is definitely a body blow, money isn't as important as health and happiness.

While the last five years has been tough for Core Laboratories shareholders, this past week has shown signs of promise. So let's look at the longer term fundamentals and see if they've been the driver of the negative returns.

View our latest analysis for Core Laboratories